| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $326.7M | +61.2% |
| Cost of Revenue | $151.7M | +54.4% |
| Gross Profit | $175.0M | +67.5% |
| R&D Expense | $118.9M | +11.3% |
| SG&A Expense | $116.5M | +14.0% |
| Operating Income | -$67.0M | +41.9% |
| Pre-tax Income | -$42.3M | +54.6% |
| Income Tax | $598K | +23.0% |
| Net Income | -$42.9M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $45.0M | +17.9% |
| Inventory | $81.6M | +6.3% |
| Current Assets | $949.3M | +74.5% |
| Total Assets | $1.29B | +46.3% |
| Current Liabilities | $84.0M | -22.5% |
| Total Liabilities | $138.5M | -25.2% |
| Stockholders' Equity | $1.16B | +65.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $87.2M | +275.8% |
| Capital Expenditures | $52.0M | +43.7% |
| Investing Cash Flow | -$427.9M | -760.7% |
| Financing Cash Flow | $351.4M | +484.8% |
| Free Cash Flow | $35.1M | +369.6% |
| +54.2% |
| EPS (Basic) | -$1.72 | +57.5% |
| EPS (Diluted) | -$1.72 | +57.5% |